Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Gross Profit 2011-2025 | MKKGY

Merck annual/quarterly gross profit history and growth rate from 2011 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Merck gross profit for the quarter ending June 30, 2025 was $3.436B, a 1.3% decline year-over-year.
  • Merck gross profit for the twelve months ending June 30, 2025 was $13.511B, a 2.75% increase year-over-year.
  • Merck annual gross profit for 2024 was $13.51B, a 0.72% increase from 2023.
  • Merck annual gross profit for 2023 was $13.413B, a 7.11% decline from 2022.
  • Merck annual gross profit for 2022 was $14.44B, a 1.06% decline from 2021.
Merck Annual Gross Profit
(Millions of US $)
2024 $13,510
2023 $13,413
2022 $14,440
2021 $14,595
2020 $12,221
2019 $11,364
2018 $11,165
2017 $11,311
2016 $10,870
2015 $9,730
2014 $10,600
2013 $10,763
2012 $10,308
2011 $9,915
2010 $12,338
Merck Quarterly Gross Profit
(Millions of US $)
2025-06-30 $3,436
2025-03-31 $3,313
2024-12-31 $3,304
2024-09-30 $3,457
2024-06-30 $3,482
2024-03-31 $3,267
2023-12-31 $3,123
2023-09-30 $3,277
2023-06-30 $3,449
2023-03-31 $3,564
2022-12-31 $3,470
2022-09-30 $3,685
2022-06-30 $3,681
2022-03-31 $3,603
2021-12-31 $3,731
2021-09-30 $3,672
2021-06-30 $3,683
2021-03-31 $3,508
2020-12-31 $3,340
2020-09-30 $3,122
2020-06-30 $2,763
2020-03-31 $2,996
2019-12-31 $2,987
2019-09-30 $2,865
2019-06-30 $2,829
2019-03-31 $2,683
2018-12-31 $2,601
2018-09-30 $2,796
2018-06-30 $2,854
2018-03-31 $2,914
2017-12-31 $2,908
2017-09-30 $2,854
2017-06-30 $2,816
2017-03-31 $2,734
2016-12-31 $2,696
2016-09-30 $2,760
2016-06-30 $2,813
2016-03-31 $2,601
2015-12-31 $2,537
2015-09-30 $2,444
2015-06-30 $2,437
2015-03-31 $2,366
2014-12-31 $2,114
2014-09-30 $2,638
2014-06-30 $2,690
2014-03-31 $2,644
2013-12-31 $2,672
2013-09-30 $2,687
2013-06-30 $2,767
2013-03-31 $2,625
2012-12-31 $3,646
2012-09-30 $2,570
2012-06-30 $2,482
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $2,583
2011-03-31 $3,505
2010-12-31 $3,707
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.414B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.69
Zoetis (ZTS) United States $53.099B 19.00
Takeda Pharmaceutical (TAK) Japan $43.243B 8.82
Daiichi Sankyo, - (DSNKY) Japan $42.092B 20.96
BeOne Medicines - (ONC) Switzerland $35.245B 0.00
Sandoz Group AG (SDZNY) Switzerland $29.520B 0.00
United Therapeutics (UTHR) United States $19.266B 16.95
Neurocrine Biosciences (NBIX) United States $15.330B 36.78
Shionogi (SGIOY) Japan $14.275B 13.11
Summit Therapeutics (SMMT) United States $13.935B 0.00
Ionis Pharmaceuticals (IONS) United States $12.096B 0.00
IPSEN (IPSEY) France $12.095B 0.00
Madrigal Pharmaceuticals (MDGL) United States $10.808B 0.00
Orion OYJ (ORINY) Finland $9.208B 26.31
Eisai (ESAIY) $8.260B 0.00
Corcept Therapeutics (CORT) United States $8.063B 87.10
Stevanato Group S.p.A (STVN) Italy $7.571B 44.64
Grifols, S.A (GRFS) Spain $5.934B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.142B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.294B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.005B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.672B 17.45
Centessa Pharmaceuticals (CNTA) United Kingdom $3.016B 0.00
Dyne Therapeutics (DYN) United States $2.973B 0.00
Hypermarcas (HYPMY) Brazil $2.936B 22.07
Catalyst Pharmaceuticals (CPRX) United States $2.617B 8.38
Soleno Therapeutics (SLNO) United States $2.517B 0.00
Ocular Therapeutix (OCUL) United States $2.303B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.905B 22.58
Avadel Pharmaceuticals (AVDL) Ireland $1.841B 0.00
Guardian Pharmacy Services (GRDN) United States $1.836B 0.00
Xeris Biopharma Holdings (XERS) United States $1.594B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.510B 89.62
Ardelyx (ARDX) United States $1.446B 0.00
Harrow (HROW) United States $1.311B 0.00
Evotec AG (EVO) Germany $1.188B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.181B 0.00
Oruka Therapeutics (ORKA) United States $1.134B 0.00
Collegium Pharmaceutical (COLL) United States $1.129B 6.17
Relay Therapeutics (RLAY) United States $1.129B 0.00
Enliven Therapeutics (ELVN) United States $1.096B 0.00
Nektar Therapeutics (NKTR) United States $1.032B 0.00
Xencor (XNCR) United States $1.025B 0.00
Cronos Group (CRON) Canada $0.938B 0.00
ARS Pharmaceuticals (SPRY) United States $0.894B 0.00
ProKidney (PROK) United States $0.795B 0.00
Theravance Biopharma (TBPH) United States $0.753B 62.29
Savara (SVRA) United States $0.697B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.687B 6.13
Elite Pharmaceuticals (ELTP) United States $0.660B 0.00
Bioventus (BVS) United States $0.610B 12.51
Siga Technologies (SIGA) United States $0.604B 7.46
Aquestive Therapeutics (AQST) United States $0.598B 0.00
Esperion Therapeutics (ESPR) United States $0.593B 0.00
Zevra Therapeutics (ZVRA) United States $0.565B 0.00
Akebia Therapeutics (AKBA) United States $0.562B 0.00
KalVista Pharmaceuticals (KALV) United States $0.555B 0.00
Organogenesis (ORGO) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.491B 0.00
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
USANA Health Sciences (USNA) United States $0.373B 10.41
Galectin Therapeutics (GALT) United States $0.363B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.335B 51.50
Altimmune (ALT) United States $0.331B 0.00
Lyell Immunopharma (LYEL) United States $0.318B 0.00
Korro Bio (KRRO) United States $0.304B 0.00
Aldeyra Therapeutics (ALDX) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.267B 0.00
Achieve Life Sciences (ACHV) Canada $0.252B 0.00
Nature's Sunshine Products (NATR) United States $0.249B 16.24
Aclaris Therapeutics (ACRS) United States $0.245B 0.00
Pyxis Oncology (PYXS) United States $0.243B 0.00
Journey Medical (DERM) United States $0.233B 0.00
AleAnna (ANNA) United States $0.217B 0.00
Avalo Therapeutics (AVTX) United States $0.216B 0.00
OmniAb (OABI) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.193B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Protara Therapeutics (TARA) United States $0.171B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.159B 0.00
Cassava Sciences (SAVA) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
Incannex Healthcare (IXHL) Australia $0.131B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Surrozen (SRZN) United States $0.106B 0.00
Context Therapeutics (CNTX) United States $0.101B 0.00
Champions Oncology (CSBR) United States $0.094B 34.00
Avita Medical (RCEL) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Metagenomi (MGX) United States $0.085B 0.00
Relmada Therapeutics (RLMD) United States $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.081B 0.00
Prelude Therapeutics (PRLD) United States $0.079B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
VAXART, INC (VXRT) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
BioNxt Solutions (BNXTF) Canada $0.069B 0.00
Gain Therapeutics (GANX) United States $0.066B 0.00
Lite Strategy (LITS) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Talphera (TLPH) United States $0.059B 0.00
Wellgistics Health (WGRX) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
Plus Therapeutics (PSTV) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Karyopharm Therapeutics (KPTI) United States $0.046B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Inotiv (NOTV) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Liminatus Pharma (LIMN) United States $0.035B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.035B 29.12
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.022B 0.00
Vyome Holdings (HIND) United States $0.022B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Ainos (AIMD) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
BioLineRx (BLRX) Israel $0.015B 0.00
Lipocine (LPCN) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
NewcelX (NCEL) Switzerland $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.35
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00